Prolonged ketosis and glycosuria secondary to SGLT2 inhibitor therapy

Abstract Clinicians should be aware of the potential for the pharmacologic activity of SGLT2 inhibitors to persist long after the standard drug clearance period of five half‐lives, the typical duration used to guide pre‐operative medication recommendations.

Guardado en:
Detalles Bibliográficos
Autores principales: David Bobrowski, Reha Kumar, Peter E. Wu, Lauren Lapointe‐Shaw
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
R
Acceso en línea:https://doaj.org/article/34c939d53002417eb7eb7864524bb8df
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Abstract Clinicians should be aware of the potential for the pharmacologic activity of SGLT2 inhibitors to persist long after the standard drug clearance period of five half‐lives, the typical duration used to guide pre‐operative medication recommendations.